Transfer pricing at heart of Pfizer case
Shareholders allege that Pfizer has deliberately contributed to poor results at its Pakistan operations, thus diluting the value of the minority stakeholders’ shares
Reply to comment
As a Pakistani it is alarming to learn about one of the pioneer multinationals
in the country,and leading worldwide,such
as Pfizer.It is anybody's guess now why
prices of their drugs are hurting patients.I commend Leela Parker to have uncovered such a story specially on eve of my firs year of MBA.
Faizan